Old Web
English
Sign In
Acemap
>
authorDetail
>
Douglas Stuart Greene
Douglas Stuart Greene
Amicus Therapeutics
Pharmacological chaperone
Pharmacology
fabry patient
Biology
Diabetes mellitus
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacokinetics and muscle distribution of AT2220, a pharmacological chaperone of acid-glucosidase, in healthy volunteers
2011
Molecular Genetics and Metabolism
Mathews Adera
Pol Boudes
Alexander Bragat
Sheela Sitaraman
Richard Lazauskas
Ken Valenzano
George R. Lankas
Randall Stoltz
Jane Royalty
Douglas Stuart Greene
Show All
Source
Cite
Save
Citations (1)
A pharmacogenetic analysis of Fabry patient responses to pharmacological chaperone treatment with AT1001 (migalastat hydrochloride)
2011
Molecular Genetics and Metabolism
Elfrida R. Benjamin
Xiaoyang Wu
M. Cecilia Della Valle
Evan Katz
Raphael Schiffmann
Jeffrey P. Castelli
Douglas Stuart Greene
Mathews Adera
Pol Boudes
David J. Lockhart
Kenneth J. Valenzano
Show All
Source
Cite
Save
Citations (0)
Pharmacological chaperones aren't just for mutant enzymes anymore: Co-administration of AT1001 Stabilizes rh∂-Gal A, leading to greater uptake and substrate reduction in fabry patient-derived cells and GLA knockout mice
2011
Molecular Genetics and Metabolism
Richie Khanna
Elfrida R. Benjamin
John J. Flanagan
Lee Pellegrino
Adriane Schilling
Kate Chang
Michelle Frascella
Yi Lun
Mathews Adera
Douglas Stuart Greene
David J. Lockhart
Kenneth J. Valenzano
Show All
Source
Cite
Save
Citations (0)
1